A Closer Look at Global Health Research and Development

By HEOR Staff Writer

December 29, 2023

Global Health Research and Development

Advancing Health Research on a Global Scale

Global Observatory on Health Research and Development (R&D) of the World Health Organisation (WHO) has just debuted its most current results. The report’s depiction of severe inequalities in the allocation of resources, money, and capacity for global health research was not unexpected. There is obviously a divide between nations with high incomes and those with low or medium incomes. The publication of this finding in the journal Health Research Policy and Systems highlights the importance of thoroughly reevaluating strategies and financial decisions for health research and development.

The Critical Need to Resolve Past Inequities

The recent COVID-19 pandemic and other outbreaks such as mpox underscore the urgent need for a fairer allocation of health research funds. Despite numerous discussions and proposals, the disparity in resource distribution between wealthy and poor nations remains largely unaddressed. This issue is critical not only for disaster preparedness but also for the global goal of improving population health equitably.

Important Results from the Worldwide Health Research and Development Project

The report highlighted four major issues. In 2020, low-income nations received just 0.2% of all grant funding, highlighting the huge disparity in this area. As a second point, the disparity in research capacity is exacerbated by the fact that high-income nations have around 56 times more health researchers per million resident than low-income countries. Third, there is a dearth of research training possibilities in low-income nations due to the low density of higher education institutions relative to the population. Finally, the suggested goals for health R&D spending as a proportion of GDP were unmet by a number of nations.

The Need to Take Action

Consistent gaps in health research capacity and financing are highlighted by the results. There has been no improvement in decades of acknowledgment. The paper recommends a systematic approach to data collection and prioritises research. It promotes frequent data exchange and advocates for global collaboration in solving these problems.

The Global Observatory on Health Research and Development remains a vital tool today. It monitors and analyses data on health research and development. It highlights both the opportunities and challenges in this crucial sector. If the international community collaborates to bridge the knowledge gap, we can improve health outcomes for all. 

Reference url

Recent Posts

MDD treatment modeling
Pioneering MDD Treatment Modeling for Optimal Care Pathways

By João L. Carapinha

June 8, 2026

MDD treatment modeling demonstrates that sequenced interventions for major depressive disorder consistently deliver superior quality-adjusted life years and net monetary benefits compared with no active treatment. All examined pathways outperformed inaction, with an SSRI-first sequence followed b...
Levacetylleucine A-T treatment
Transformative Impact of Levacetylleucine A-T Treatment in Rare Neurodegenerative Disease

By HEOR Staff Writer

June 8, 2026

Levacetylleucine A-T treatment has delivered compelling Phase III results, producing statistically significant and clinically meaningful improvements in ataxia severity and daily function for both pediatric and adult patients with ataxia-telangiectasia (A-T). The
Insulin Cost Policy Impact
Insulin Cost Policy Impact on Medicare Beneficiaries

By HEOR Staff Writer

June 8, 2026

The Insulin Cost Policy Impact became clear in 2023 after the Inflation Reduction Act limited out-of-pocket insulin expenses to $35 per 30-day supply for Medicare Part D beneficiaries. According to a JAMA Network study, the c...